Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
Bharti Wadhwa(Maulana Azad Medical College), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Bethany Mills(MRC Centre for Regenerative Medicine), Erin Gaughan(Edinburgh Royal Infirmary), Sukhyanti Kerai(Maulana Azad Medical College), Kirti N Saxena(Maulana Azad Medical College), Farah Husain(Oregon Health & Science University), Nalini Bala Pandey(Maulana Azad Medical College), Kevin Dhaliwal(Edinburgh Royal Infirmary), Keith Finlayson(Centre for Inflammation Research), Jean Antonelli(Centre for Inflammation Research), Feng Li(Centre for Inflammation Research), Vikas Malhotra(Maulana Azad Medical College), Vinay Singh(Maulana Azad Medical College), Anne Moore(Centre for Inflammation Research), Tom Quinn(Edinburgh Royal Infirmary), Annya Bruce(Centre for Inflammation Research), Manu Shankar‐Hari(Centre for Inflammation Research)
Cited by 2
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668